GDR genedrive plc

0.0119USD0.9000 GBp · LSE0.00%Mkt Cap: 19.03M USDP/E: —

genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The co…

Key Statistics

Company
Market Cap19.03M USD
Enterprise Value12.35M USD
Revenue (TTM)1.55M USD
Gross Profit-4.39M USD
Net Income (TTM)-6.89M USD
Revenue/Share0.0026 USD
Last Price0.0119 USD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees43
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISINGB00B1VKB244
Valuation
P/E (Trailing)—
P/E (Forward)0.00
PEG—
EV/EBITDA-1.74
EV/Revenue7.99
P/S12.31
P/B—
EPS (TTM)-0.01 USD
EPS (Forward)2.77 USD
52W Range
0.009422% of range0.0204
52W High0.0204 USD
52W Low0.0094 USD
Profitability
Gross Margin-283.99%
Oper. Margin-462.44%
EBITDA Margin0.00%
Profit Margin-684.69%
ROE-363.77%
ROA-185.83%
ROIC-2026.04%
ROCE-374.13%
Growth
Revenue Growth62.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.77M USD
CapEx (TTM)30.29K USD
FCF Margin-173.52%
FCF Yield-14.10%
Net Debt148.80K USD
Net Debt/EBITDA-0.02
Net Debt/FCF—
Balance Sheet
Debt/Equity0.00
Current Ratio0.99
Quick Ratio0.78
Book Value/Sh0.00 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.61B
Float633.92M
Insiders44.96%
Institutions1.24%
Technical
SMA 500.0145 (-18.3%)
SMA 2000.0147 (-19.4%)
Beta1.28
S&P 52W Chg12.08%
Avg Vol (30d)2.45M
Avg Vol (10d)3.09M
Technical Indicators
RSI (14)29.4
MACD-0.0539
MACD Signal-0.0588
MACD Hist.+0.0049
BB Upper0.0140 USD
BB Middle0.0124 USD
BB Lower0.0108 USD
BB Width25.70%
ATR (14)0.0012 USD
Vol Ratio (20d)1.42x

About genedrive (LON: GDR)

›

genedrive (LON: GDR) is listed on the London Stock Exchange, where its shares trade in pence sterling (GBp). It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 43 employees.

The shares were at 0.9000 GBp on 19 November 2026, up 19.2% over 52 weeks. Its 52-week range is 0.7150 GBp to 1.550 GBp: the price is 41.9% below the high and 25.9% above the low.

Its market capitalisation is 14.45M GBP.

genedrive reports return on equity of -363.8%, an operating margin of -462.4% and revenue up 62.9% year over year.

Its debt exceeds its cash by 113.00K GBP. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.